Delivery Order SPE2DB24D2105-SPE2DB25FAQFK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Diltiazem 12-hour extended-release 120 mg capsules (100-count units) with a ceiling value of $1,082.04. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 22, 2025, for Diltiazem 12-hour extended-release 60 mg capsules (100 count) with a ceiling value of $1,444.37. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,206.81 on August 18, 2025, for the supply of Diltiazem 12-hour extended-release 60 mg capsules (100-count bottles). The contract is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $12,787.76 to AmerisourceBergen Drug Corp for the supply of Diltiazem 12HR ER 60 mg capsules (100-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under a larger contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.78 firm fixed-price contract is for the delivery of Diltiazem 12HR ER 60 mg capsules (100 count) to support military healthcare programs. The contract has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a $3,780.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for Diltiazem 12HR ER 60 MG Capsules (100s), a prescription medication. This award falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,230.56, is for the delivery of Diltiazem 12HR ER 60 mg capsules over a period ending on April 29, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,333.62 firm fixed-price contract is for the provision of Diltiazem 12HR ER 60 MG capsules, a cardiovascular medication, to support military and federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $35,120 to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 120mg extended release diltiazem capsules to support Defense Department requirements. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania within the period of performance between August 8-9, 2023. The Defense Logistics Agency routinely...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirteen thousand one hundred seventy dollars to Amerisourcebergen Drug Corporation for the supply of ninety capsules of 120mg Diltiazem HCl extended release capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 24, 2023 through July 25, 2023. As the DLA supports procurement for the Department of Defense, this...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQFKDelivery Order
The Defense Logistics Agency awarded a $4,533.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 units of Diltiazem 12-hour extended-release 60 mg capsules. This contract, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award involved no set-aside designation and was competitively awarded. Performance of this pharmaceutical delivery will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 prime IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as the company's primary vehicle for supplying pharmaceuticals and medical supplies to support military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive portfolio of medications across multiple therapeutic domains, including brand-name and generic drugs, vaccines, and medical devices. The delivery of this cardiovascular medication supports DLA's broader mission to ensure adequate medical supply availability for Department of Defense and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 9/15/25 |